Jump Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
1,177
-2,013
-63% -$395K ﹤0.01% 1754
2026
Q1
$625K Buy
3,190
+1,065
+50% +$207K 0.01% 1136
2025
Q4
$369K Sell
2,125
-2,174
-51% -$396K ﹤0.01% 1447
2025
Q3
$819K Sell
4,299
-416
-9% -$73.8K 0.01% 1095
2025
Q2
$847K Sell
4,715
-5,804
-55% -$1.01M 0.01% 1042
2025
Q1
$1.78M Buy
10,519
+8,019
+321% +$1.32M 0.02% 619
2024
Q4
$377K Sell
2,500
-2,661
-52% -$414K 0.01% 1211
2024
Q3
$801K Buy
5,161
+2,411
+88% +$360K 0.02% 895
2024
Q2
$376K Sell
2,750
-18,447
-87% -$2.53M 0.01% 1270
2024
Q1
$2.82M Buy
21,197
+17,197
+430% +$2.23M 0.08% 307
2023
Q4
$552K Sell
4,000
-3,986
-50% -$524K 0.02% 1004
2023
Q3
$973K Buy
7,986
+4,377
+121% +$583K 0.04% 677
2023
Q2
$507K Buy
3,609
+1,159
+47% +$160K 0.02% 1025
2023
Q1
$347K Buy
+2,450
New +$351K 0.01% 1051
2022
Q2
Sell
-5,591
Closed -$765K 1702
2022
Q1
$765K Buy
+5,591
New +$779K 0.03% 629
2021
Q4
Sell
-22,943
Closed -$3.33M 1453
2021
Q3
$3.33M Buy
+22,943
New +$3.36M 0.24% 35
2021
Q2
Sell
-5,957
Closed -$764K 1144
2021
Q1
$764K Buy
5,957
+3,857
+184% +$475K 0.07% 292
2020
Q4
$250K Sell
2,100
-263
-11% -$32.1K 0.04% 674
2020
Q3
$271K Buy
+2,363
New +$279K 0.05% 529

Other funds holding DGX

Jump Financial's DGX Position: Q2 2026 in Review

Jump Financial reduced its Quest Diagnostics (DGX) stake by 63% in Q2 2026, selling an estimated $395K and leaving 1,177 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Jump Financial first reported a position in DGX in Q3 2020 and has held it in 19 quarters since. The position peaked at $3.33M in Q3 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Jump Financial held 1,177 shares of Quest Diagnostics worth $249K as of Q2 2026.
  • Jump Financial sold 2,013 Quest Diagnostics shares in Q2 2026, an estimated $395K.
  • Quest Diagnostics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1754 holding.
  • Jump Financial first reported a position in Quest Diagnostics in Q3 2020 and has held it in 19 quarters since.
  • Jump Financial's Quest Diagnostics position peaked at $3.33M in Q3 2021.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.